In adults with multiple sclerosis, how does alemtuzumab compare with other drug therapies?doi:10.1002/CCA.1480S. TortJohn Wiley & Sons, Ltd
Another monoclonal antibody,Campath (alemtuzumab), targets the CD52 protein and is used when initial therapies are ineffective.8 Adverse side effects includeallergic reaction, chest pain/racing heart, dizziness, infection risk, and tumor lysis syndrome. Chemotherapy For many years,oral chemotherapywithLe...